#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Mucopolysaccharidosis III Glycogen storage disease type II Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome IgA nephropathy Fragile X syndrome Anaplastic thyroid cancer Burkitt's lymphoma Glomerulonephritis chronic Adenoid cystic carcinoma Oesophageal adenocarcinoma Gastrointestinal neuroendocrine tumour Non-Hodgkin's lymphoma unspecified histology indolent Ataxia telangiectasia Langerhans' cell histiocytosis Renal cancer metastatic More trials…
Learn about Rare Diseases

Atypical haemolytic uraemic syndrome – Diagnostics Crigler-Najjar syndrome – Diagnostics Rosai-Dorfman syndrome – Trials in Disease Glomerulonephritis membranoproliferative – Life with Disease Mantle cell lymphoma refractory – Diagnostics Alexander disease – Trials in Disease VEXAS syndrome Breast angiosarcoma metastatic – Basic Information Hepatoblastoma – Basic Information Testicular leiomyosarcoma More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Ertapenem PALAZESTRANT Ascorbic Acid Bp Imipenem Atazanavir ACICLOVIR SODIUM Bleomycin Sulfate Oxybutynin Azd5492 Clic-1901 Cart Specific Nucleic Acid Sna-Xfsa Panobinostat Amg 193 Alkaline Phosphatase, Bovine Lt3001 Db-Oto-3 TETANUS TOXOID Haloperidol Decanoate Mifamurtide Fostemsavir More therapies…

Learn about Your Condition

Idiopathic pulmonary fibrosis Pneumococcal infection Impaired gastric emptying Stress Mitochondrial DNA depletion Diabetic foot infection Ankylosing spondylitis Angiopathy Abdominal infection Fabry's disease Hernia repair Anal cancer stage II Haemodialysis Migraine without aura Joint stabilisation More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Schizoaffective disorder

Study on the Effects of GT-002 and Oxazepam for Cognitive Impairment in Schizophrenia Patients

Recruiting

2 1 1
Investigated Diseases:
Investigated Drugs:
- GT-002
- Oxazepam
Study on Melatonin and Quetiapine for Treating Insomnia in Adolescents with Psychiatric Disorders

Recruiting

4 1 1
Investigated Diseases:
Investigated Drugs:
- Melatonin
- Quetiapine
Study on the Effect of Clozapine and Drug Combination for Patients with Schizophrenia Experiencing First-Line Treatment Failure

Recruiting

3 1 1 1
Investigated Drugs:
Study on the Safety and Effectiveness of Olanzapine for Patients with Schizophrenia

Not recruiting

3 1 1 1
Investigated Diseases:
- Schizoaffective disorder
- Schizophrenia
Investigated Drugs:
- Olanzapine

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Schizoaffective disorder

Study on the Effects of GT-002 and Oxazepam for Cognitive Impairment in Schizophrenia Patients

Study on Melatonin and Quetiapine for Treating Insomnia in Adolescents with Psychiatric Disorders

Study on the Effect of Clozapine and Drug Combination for Patients with Schizophrenia Experiencing First-Line Treatment Failure

Study on the Safety and Effectiveness of Olanzapine for Patients with Schizophrenia

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies